David I. Min

1.6k total citations
52 papers, 1.3k citations indexed

About

David I. Min is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, David I. Min has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Transplantation, 19 papers in Pediatrics, Perinatology and Child Health and 11 papers in Psychiatry and Mental health. Recurrent topics in David I. Min's work include Renal Transplantation Outcomes and Treatments (21 papers), Pharmacological Effects and Toxicity Studies (17 papers) and Neurological Complications and Syndromes (6 papers). David I. Min is often cited by papers focused on Renal Transplantation Outcomes and Treatments (21 papers), Pharmacological Effects and Toxicity Studies (17 papers) and Neurological Complications and Syndromes (6 papers). David I. Min collaborates with scholars based in United States, South Korea and Switzerland. David I. Min's co-authors include Mi‐Young Lee, Tariq Shah, Michael J. Flanigan, Vicki L. Ellingrod, Vicki L. Ellingrod, Anthony P. Monaco, Hsiang‐Yin Chen, Robert Naraghi, Jae Wook Yang and Ian V. Hutchinson and has published in prestigious journals such as Acta Materialia, Transplantation and Clinical Pharmacology & Therapeutics.

In The Last Decade

David I. Min

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David I. Min United States 21 515 387 359 237 203 52 1.3k
Iain MacPhee United Kingdom 24 1.1k 2.1× 882 2.3× 550 1.5× 415 1.8× 283 1.4× 71 2.4k
Gabriele Kirchner Germany 25 547 1.1× 259 0.7× 366 1.0× 200 0.8× 681 3.4× 54 2.0k
Joachim Grevel United States 24 955 1.9× 704 1.8× 266 0.7× 150 0.6× 450 2.2× 64 2.2k
Darlene Barr United States 16 169 0.3× 263 0.7× 547 1.5× 644 2.7× 346 1.7× 33 1.6k
Julia M. Barbarino United States 13 160 0.3× 356 0.9× 449 1.3× 567 2.4× 139 0.7× 14 1.6k
Alexandra Tsaroucha Greece 24 478 0.9× 129 0.3× 348 1.0× 96 0.4× 845 4.2× 114 2.0k
Kathleen M. Tornatore United States 18 352 0.7× 218 0.6× 85 0.2× 84 0.4× 122 0.6× 43 818
Morton B. Brown United States 10 141 0.3× 325 0.8× 401 1.1× 216 0.9× 164 0.8× 11 900
Annick Rousseau France 30 1.6k 3.1× 694 1.8× 369 1.0× 134 0.6× 462 2.3× 74 2.5k
Richard E. Mullins United States 20 169 0.3× 259 0.7× 212 0.6× 156 0.7× 560 2.8× 50 2.2k

Countries citing papers authored by David I. Min

Since Specialization
Citations

This map shows the geographic impact of David I. Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Min more than expected).

Fields of papers citing papers by David I. Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David I. Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Min. The network helps show where David I. Min may publish in the future.

Co-authorship network of co-authors of David I. Min

This figure shows the co-authorship network connecting the top 25 collaborators of David I. Min. A scholar is included among the top collaborators of David I. Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David I. Min. David I. Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Shah, Tariq, et al.. (2016). Clinical risk factors associated with the post-transplant anemia in kidney transplant patients. Transplant Immunology. 38. 50–53. 9 indexed citations
4.
5.
Shah, T., et al.. (2015). Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients. Transplantation Proceedings. 47(2). 394–398. 71 indexed citations
6.
Shah, Tariq, Don Vu, J Cicciarelli, et al.. (2012). Effects of mycophenolic acid on highly sensitized patients awaiting kidney transplant. Transplant Immunology. 28(1). 32–37. 1 indexed citations
7.
Law, Anandi V., et al.. (2012). Impact of a Faculty Orientation and Development Committee. American Journal of Pharmaceutical Education. 76(1). 3–3. 9 indexed citations
8.
Shah, Tariq, Jae Wook Yang, Yasir Qazi, et al.. (2010). The Pharmacokinetics of Enteric-Coated Mycophenolate Sodium and Its Gastrointestinal Side Effects in De Novo Renal Transplant Recipients of Hispanic Ethnicity. Therapeutic Drug Monitoring. 33(1). 45–49. 8 indexed citations
9.
Yang, Jae Wook, et al.. (2009). Genetic Polymorphisms of MRP2 and UGT2B7 and Gastrointestinal Symptoms in Renal Transplant Recipients Taking Mycophenolic Acid. Therapeutic Drug Monitoring. 31(5). 542–548. 24 indexed citations
10.
Min, David I. & Vicki L. Ellingrod. (2002). C3435T Mutation in Exon 26 of the Human MDR1 Gene and Cyclosporine Pharmacokinetics in Healthy Subjects. Therapeutic Drug Monitoring. 24(3). 400–404. 69 indexed citations
12.
Min, David I.. (2000). Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers. Clinical Pharmacology & Therapeutics. 68(5). 478–486. 66 indexed citations
13.
Min, David I., et al.. (1999). A Urine Metabolic Ratio of Dextromethorphan and 3‐Methoxymorphinan as a Probe for CYP3A Activity and Prediction of Cyclosporine Clearance in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(6). 753–759. 15 indexed citations
14.
Min, David I., et al.. (1999). Sudden Hearing Loss Associated with Tacrolimus in a Kidney‐Pancreas Allograft Recipient. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(7). 891–893. 15 indexed citations
15.
Pescovitz, Mark D., Gary W. Barone, Miles G. Choc, et al.. (1997). SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE: TWO-YEAR DATA IN PRIMARY RENAL ALLOGRAFT RECIPIENTS. Transplantation. 63(5). 778–780. 18 indexed citations
16.
Min, David I., et al.. (1996). Effect of Grapefruit Juice on the Pharmacokinetics and Pharmacodynamics of Quinidine in Healthy Volunteers. The Journal of Clinical Pharmacology. 36(5). 469–476. 37 indexed citations
17.
Barone, Gary W., C. Martin Bunke, Miles G. Choc, et al.. (1996). THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1. Transplantation. 61(6). 968–970. 35 indexed citations
18.
Barone, Gary W., Miles G. Choc, Jon B. Klein, et al.. (1996). THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1. Transplantation. 61(6). 875–880. 82 indexed citations
19.
Kumar, Viney, et al.. (1994). Evaluation of Traditional African Medicine ???Compound R??? for the Treatment of Thermal Burn Wounds in Fuzzy Rats. Journal of Burn Care & Rehabilitation. 15(6). 519–522. 2 indexed citations
20.
Min, David I., et al.. (1992). Bioavailability and Patient Acceptance of Cyclosporine Soft Gelatin Capsules in Renal Allograft Recipients. Annals of Pharmacotherapy. 26(2). 175–179. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026